Detalhe da pesquisa
1.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774225
2.
The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
BMC Nephrol
; 18(1): 273, 2017 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851317
3.
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study.
Arthritis Care Res (Hoboken)
; 75(8): 1804-1814, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710243
4.
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
Arthritis Care Res (Hoboken)
; 75(11): 2259-2266, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221146
5.
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
J Rheumatol
; 50(11): 1471-1480, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453737
6.
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401.
J Clin Oncol
; 41(23): 3917-3929, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307514
7.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.
Clin Cancer Res
; 29(17): 3352-3361, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058595
8.
Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials.
ACR Open Rheumatol
; 4(2): 177-186, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792858
9.
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.
BMJ Open
; 12(9): e058396, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104138
10.
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria.
Eur J Cancer
; 173: 285-296, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964471